Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Pileri

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Relationship between dyskerin expression and telomerase activity in human breast cancerLorenzo Montanaro, Maria Calienni, Claudio Ceccarelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 11, 2023
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literatureRiccardo Carbonaro, Giuseppe Accardo, Luca Mazzocconi, et al.
Haematologica|March 17, 2004
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosinePier Luigi Zinzani, Monica Tani, Enrica Marchi, et al.
Hematological Oncology|July 3, 2014
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patientsPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Cancer|May 13, 2004
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphomaPier Luigi Zinzani, Vittorio Stefoni, Gerardo Musuraca, et al.
Annals of Hematology|April 23, 2014
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?Pier Luigi Zinzani, Vittorio Stefoni, Alessandro Broccoli, et al.
Hematological Oncology|December 19, 2022
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patientsEnrico Derenzini, Angela Gueli, Alessandra Risso, et al.
Oncology Reports|November 8, 2005
Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphomaEllen C Obermann, Philip Went, Ann-Christine Pehrs, et al.
Tumori|September 2, 2017
Primary bone lymphoma of the talus: a challenging diagnosisOmbretta Annibali, Gianluigi Fabbriciani, Mariantonietta Tafuri, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|October 22, 2008
Relationship between dyskerin expression and telomerase activity in human breast cancerLorenzo Montanaro, Maria Calienni, Claudio Ceccarelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 11, 2023
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literatureRiccardo Carbonaro, Giuseppe Accardo, Luca Mazzocconi, et al.
Haematologica|March 17, 2004
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosinePier Luigi Zinzani, Monica Tani, Enrica Marchi, et al.
Hematological Oncology|July 3, 2014
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patientsPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Cancer|May 13, 2004
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphomaPier Luigi Zinzani, Vittorio Stefoni, Gerardo Musuraca, et al.
Annals of Hematology|April 23, 2014
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?Pier Luigi Zinzani, Vittorio Stefoni, Alessandro Broccoli, et al.
Hematological Oncology|December 19, 2022
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patientsEnrico Derenzini, Angela Gueli, Alessandra Risso, et al.
Oncology Reports|November 8, 2005
Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphomaEllen C Obermann, Philip Went, Ann-Christine Pehrs, et al.
Tumori|September 2, 2017
Primary bone lymphoma of the talus: a challenging diagnosisOmbretta Annibali, Gianluigi Fabbriciani, Mariantonietta Tafuri, et al.
Pageof 18